VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
14 hedge funds and large institutions have $24M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 14 → 14 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
6% less capital invested
Capital invested by funds: $25.6M → $24M (-$1.57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$3.65M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.5K |
| 3 |
TFCP
Twin Focus Capital Partners
Boston,
Massachusetts
|
+$28.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.56K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.74M |
| 2 |
RI
RTW Investments
New York
|
-$1.72M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| 4 |
Morgan Stanley
New York
|
-$1.38K |
| 5 |
Goldman Sachs
New York
|
-$382 |
VBIV Hedge Fund Activity: Q4 2015 in Review
14 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2015, worth a combined $24M — down 6.1% from $25.6M a quarter earlier.
Fund positioning in VBIV was balanced in Q4 2015: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $3.65M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $1.74M sold.
- 14 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $24M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2015, down 6.1% quarter-over-quarter.
- 3 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2015 and 3 closed out, a net change of 0 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2015 was Cambridge Investment Research Advisors, an estimated $3.65M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2015 was Hudson Bay Capital Management, an estimated $1.74M sold.
Based on aggregated 13F filings for Q4 2015.